KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Work In Process (2016 - 2018)

Idexx Laboratories has reported Work In Process over the past 9 years, most recently at $18.3 million for Q1 2018.

  • Quarterly results put Work In Process at $18.3 million for Q1 2018, down 2.94% from a year ago — trailing twelve months through Mar 2018 was $18.3 million (down 2.94% YoY), and the annual figure for FY2017 was $17.8 million, up 18.59%.
  • Work In Process for Q1 2018 was $18.3 million at Idexx Laboratories, up from $17.8 million in the prior quarter.
  • Over the last five years, Work In Process for IDXX hit a ceiling of $20.3 million in Q2 2015 and a floor of $14.9 million in Q2 2014.
  • Median Work In Process over the past 5 years was $18.2 million (2015), compared with a mean of $17.6 million.
  • Biggest five-year swings in Work In Process: soared 35.86% in 2015 and later dropped 21.32% in 2016.
  • Idexx Laboratories' Work In Process stood at $16.9 million in 2014, then increased by 10.91% to $18.7 million in 2015, then fell by 19.79% to $15.0 million in 2016, then grew by 18.59% to $17.8 million in 2017, then rose by 2.62% to $18.3 million in 2018.
  • The last three reported values for Work In Process were $18.3 million (Q1 2018), $17.8 million (Q4 2017), and $18.2 million (Q3 2017) per Business Quant data.